Katsuyoshi Matsuoka

21PUBLICATIONS
90CO-AUTHORS
Clinical pharmacology and therapeuticsChemical engineering designMolecular targetsPredictive and prognostic markersPacific Peoples epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|May 12, 2026
Asian Pacific Association of Gastroenterology (APAGE) Clinical Practice Guidelines on the Use of Small Molecules and IL-23 p19 Inhibitors in Ulcerative Colitis and Crohn's Disease.

|Apr 10, 2026
Correction: Optimising carotegrast methyl use in ulcerative colitis: patient profiling, predictive biomarkers, and timing of efficacy evaluation (ASPECT study).

Katsuyoshi Matsuoka, Fumihito Hirai, Kenji Watanabe

|Feb 24, 2026
Safety and efficacy of long-term filgotinib treatment in Japanese patients with ulcerative colitis: an interim subgroup analysis of the SELECTION long-term extension study.

Katsuyoshi Matsuoka, Erina Hata, Toshihiko Kaise

|Feb 09, 2026
Beyond the mucosa: intestinal ultrasound for post-endoscopic healing risk stratification in ulcerative colitis.

Shintaro Sagami, Katsuyoshi Matsuoka, Taku Kobayashi

|Dec 22, 2025
Post-marketing Surveillance of Tofacitinib in Patients With Ulcerative Colitis in Japan: A Post Hoc Analysis of Safety and Effectiveness by Prior Biologic Status.

Katsuyoshi Matsuoka, Satoshi Motoya, Shinichiro Shinzaki

|Sep 22, 2025
Optimising carotegrast methyl use in ulcerative colitis: patient profiling, predictive biomarkers, and timing of efficacy evaluation (ASPECT study).

Katsuyoshi Matsuoka, Fumihito Hirai, Kenji Watanabe

Pageof 4

Frequent Collaborators

7 joint publications

Tadakazu Hisamatsu

5 joint publications

Toshifumi Hibi

4 joint publications

Taku Kobayashi

3 joint publications

Yohei Mikami